BOVIE MEDICAL CORPORATION (NYSEMKT:BVX) Files An 8-K Results of Operations and Financial Condition
Item 2.02 – Results of Operations and Financial Condition
a press release reporting on its results of operations for the
first>fiscal quarter ended March 31, 2017. A copy of that
press release is attached hereto as Exhibit 99.1 and incorporated
by reference herein. Such information, including the Exhibit 99.1
attached hereto, shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended,
nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933, as amended, except as shall be
expressly set forth by specific reference in such filing.
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press release dated May 15, 2017
|
About BOVIE MEDICAL CORPORATION (NYSEMKT:BVX)
Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through three segments: Core, OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor’s offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers its products in electrosurgery, cauteries and other products categories. BOVIE MEDICAL CORPORATION (NYSEMKT:BVX) Recent Trading Information
BOVIE MEDICAL CORPORATION (NYSEMKT:BVX) closed its last trading session down -0.02 at 2.65 with 49,467 shares trading hands.
